Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Linyi Dongcheng Dongyuan Biological Engineering is a Chinese pharmaceutical manufacturing company and a wholly-owned subsidiary of Yantai Dongcheng Pharmaceutical Group. Based in Linyi, Shandong Province, the company specializes in the production of heparin sodium crude and active pharmaceutical ingredients (APIs). Its operations are a vital component of the parent company's vertically integrated heparin supply chain, focusing on the extraction of biological materials from porcine sources. The facility adheres to Good Manufacturing Practice (GMP) standards to ensure the quality and safety of its biochemical products. The company's output supports the global market for anticoagulant and antithrombotic therapies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Linyi Dongcheng Dongyuan Biological Engineering.